Cavosonstat
Drug timelines are a Plus or Pro feature.
4 regulatory and trial events tracked for Cavosonstat, covering 2016-11-21 to 2020-10-23. Get the full timeline:
Most recent: Clinical Trial Update: A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Study to Evaluate the Efficacy and Safety of Cavosonstat Administered Twice Daily Compared With Placebo for 24 Weeks in Adult Subjects With Chronic Obstructive Pulmonary Disease (COPD) [Phase 2]